Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
METHOD OF USING A GIP/GLP1 CO-AGONIST FOR DIABETES
No-Receipt date
2024-03900 - 22/10/2024
No-Filing date
20240402466 - 22/10/2024
No-Granting date
3116690 - 06/11/2024
No-EPO application date
19749938.7 - 22/07/2019
No-EPO granting date
3826662 - 11/09/2024
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
11/2024 - 09/12/2024
Expiration date
23/07/2039
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201862702180 P23/07/2018/US
US201862730562 P13/09/2018/US
US201862740640 P03/10/2018/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 38/26
A61P 3/10
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1680847
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS, IN 46285
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
4396938
ALSINA-FERNANDEZ, JORGE
4396939
CABRERA, OVER
4396940
COSKUN, TAMER
Representatives
Code
Firstname
Surname
Address
Town
Zip
3463
MARIA
ATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Payments history
6 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).